Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]

We should not use PDL1 and other biomarkers for selecting patients for immune...

Prof Gordon McVie - King's College London, London, UK

We should not use PDL1 and other biomarkers for selecting patients for immune checkpoint therapies ( Prof Gordon McVie - King's College London, London, UK )

Using PDL1 and other biomarkers in patient selection for immunology: Q & A

Dr O'Brien and Prof McVie

Using PDL1 and other biomarkers in patient selection for immunology: Q & A ( Dr O'Brien and Prof McVie )

IBCD 2016: Patient access and regulatory challenges

Dr Denis Lacombe - EORTC Director General

IBCD 2016: Patient access and regulatory challenges ( Dr Denis Lacombe - EORTC Director General )

Taking complex genomic analysis into practice

Dr Philip Beer - Sanger Institute, Hinxton, UK

Taking complex genomic analysis into practice ( Dr Philip Beer - Sanger Institute, Hinxton, UK )

Genomic characterisation and risk stratification of AML

Dr Moritz Gerstung - European Bioinformatics Institute, Hinxton, UK

Genomic characterisation and risk stratification of AML ( Dr Moritz Gerstung - European Bioinformatics Institute, Hinxton, UK )

Screening Patients for Efficient Clinical Trial Access (SPECTA)

Dr Vassilis Golfinopoulos - EORTC, Brussels, Belgium

Screening Patients for Efficient Clinical Trial Access (SPECTA) ( Dr Vassilis Golfinopoulos - EORTC, Brussels, Belgium )

IBCD 2016: Integrating assays into clinical trials

Dr Tracy Lively - National Cancer Institute, USA

IBCD 2016: Integrating assays into clinical trials ( Dr Tracy Lively - National Cancer Institute, USA )

Design and value of immunohistochemical assays

Dr Stephen Hewitt - National Institutes of Health, Bethesda, USA

Design and value of immunohistochemical assays ( Dr Stephen Hewitt - National Institutes of Health, Bethesda, USA )

Oncolytic virotherapy in the treatment of melanoma

Dr Robert Andtbacka - Huntsman Cancer Institute, Salt Lake City, USA

Oncolytic virotherapy in the treatment of melanoma ( Dr Robert Andtbacka - Huntsman Cancer Institute, Salt Lake City, USA )

What is the role of surgery in melanoma treatment?

Dr Alessandro Testori - Istituto Europeo di Oncologia, Milan, Italy

What is the role of surgery in melanoma treatment? ( Dr Alessandro Testori - Istituto Europeo di Oncologia, Milan, Italy )

The role of chemotherapy for metastatic melanoma

Prof Paul Lorigan - University of Manchester, Manchester, UK

The role of chemotherapy for metastatic melanoma ( Prof Paul Lorigan - University of Manchester, Manchester, UK )

NCI CARs for childhood ALL and neuroblastoma: the promise and potential pitfalls

Dr Daniel Lee - University of Virginia, Charlottesville, USA

NCI CARs for childhood ALL and neuroblastoma: the promise and potential pitfalls ( Dr Daniel Lee - University of Virginia, Charlottesville, USA )

More from ecancer